(MT Newswires) -- Dutch Philips Group (PHG) CEO Roy Jakobs discusses the consequences of the sleep apnea machine recall. The Dutch medical equipment manufacturer has not given a definitive figure for the cost of the recall, as the legal proceedings are not over, but claims that 99% of defective devices have been replaced. While the company has recorded three consecutive quarters of growth, it points to investments in artificial intelligence, estimated at over a billion euros a year.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.88 EUR | -1.43% | +0.73% | +22.03% |
May. 24 | Philips: refinancing for 700 million euros | CF |
May. 24 | Royal Philips Prices EUR700 Million of Notes due 2032 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.03% | 25.65B | |
+7.01% | 215B | |
+11.01% | 187B | |
+19.20% | 143B | |
+30.79% | 110B | |
+1.48% | 64.68B | |
+13.95% | 52.96B | |
-0.16% | 49.84B | |
-6.20% | 38.32B | |
+0.91% | 35.86B |
- Stock Market
- Equities
- PHIA Stock
- News Philips NV
- Product recalls, renewed growth, investment in AI. Roy Jakobs, Philips CEO